M Bayer1. 1. Department of Pediatrics, Faculty of Medicine in Hradec Králové, Charles University and University Hospital Hradec Králové, Sokolská 581, 500 05, Hradec Králové, Czech Republic, bayerm@lfhk.cuni.cz.
Abstract
UNLABELLED: The aim of this study was to assess the relationships between both a marker of bone formation and a marker of bone turnover and age, sex, and pubertal stage in a group (n = 439) of healthy children and adolescents. These reference data should be instrumental in interpretation of results. INTRODUCTION: The skeletal system has high metabolic activity. In children, bone markers may be useful in diagnostics and treatment management of skeletal diseases but there could be difficulties with interpretation of results. Compared with adults, children have elevated bone marker levels due to high skeletal growth velocity and rapid bone turnover. Thus, valid age- and sex-specific reference data should be obtained for each pediatric population living in a particular climate and with a similar lifestyle. The aim of this study was to assess the relationships between both a marker of bone formation (procollagen type I N-terminal propeptide [PINP]) and a marker of bone turnover (osteocalcin [OC]) and age, sex, and pubertal stage in a group of healthy children and adolescents. METHODS: Four hundred thirty-nine healthy Caucasian children participated. Their height, weight, and pubertal stage were recorded. Fasting PINP and OC were measured using a morning blood sample. RESULTS: The highest levels of PINP were observed during the first year of life. There is no OC postnatal peak, but levels are higher than the adult reference interval throughout childhood. OC peaks with the pubertal growth spurt at second-third Tanner stage of breast development in girls and at second-third Tanner stage of genital development in boys. PINP peaks during second-third Tanner stage of breast development in girls and at third Tanner stage of genital development in boys. CONCLUSION: This study provides reference data for OC and PINP in healthy Caucasian children from a Central European population.
UNLABELLED: The aim of this study was to assess the relationships between both a marker of bone formation and a marker of bone turnover and age, sex, and pubertal stage in a group (n = 439) of healthy children and adolescents. These reference data should be instrumental in interpretation of results. INTRODUCTION: The skeletal system has high metabolic activity. In children, bone markers may be useful in diagnostics and treatment management of skeletal diseases but there could be difficulties with interpretation of results. Compared with adults, children have elevated bone marker levels due to high skeletal growth velocity and rapid bone turnover. Thus, valid age- and sex-specific reference data should be obtained for each pediatric population living in a particular climate and with a similar lifestyle. The aim of this study was to assess the relationships between both a marker of bone formation (procollagen type I N-terminal propeptide [PINP]) and a marker of bone turnover (osteocalcin [OC]) and age, sex, and pubertal stage in a group of healthy children and adolescents. METHODS: Four hundred thirty-nine healthy Caucasian children participated. Their height, weight, and pubertal stage were recorded. Fasting PINP and OC were measured using a morning blood sample. RESULTS: The highest levels of PINP were observed during the first year of life. There is no OC postnatal peak, but levels are higher than the adult reference interval throughout childhood. OC peaks with the pubertal growth spurt at second-third Tanner stage of breast development in girls and at second-third Tanner stage of genital development in boys. PINP peaks during second-third Tanner stage of breast development in girls and at third Tanner stage of genital development in boys. CONCLUSION: This study provides reference data for OC and PINP in healthy Caucasian children from a Central European population.
Authors: R Eastell; N Mallinak; S Weiss; M Ettinger; M Pettinger; D Cain; K Fressland; C Chesnut Journal: J Bone Miner Res Date: 2000-03 Impact factor: 6.741
Authors: Kathleen M Hill; Emma M Laing; Dorothy B Hausman; Anthony Acton; Berdine R Martin; George P McCabe; Connie M Weaver; Richard D Lewis; Munro Peacock Journal: Bone Date: 2012-06-28 Impact factor: 4.398
Authors: G Manjón Llorente; C Fernández-Espuelas; J Ma González López; M P Ruiz-Echarri; A Baldellou Vázquez Journal: An Pediatr (Barc) Date: 2004-04 Impact factor: 1.500
Authors: Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis Journal: Clin Chem Lab Med Date: 2011-05-24 Impact factor: 3.694
Authors: D Herrmann; T Intemann; F Lauria; S Mårild; D Molnár; L A Moreno; I Sioen; M Tornaritis; T Veidebaum; I Pigeot; W Ahrens Journal: Int J Obes (Lond) Date: 2014-09 Impact factor: 5.095
Authors: L N Mosca; T B L Goldberg; V N da Silva; C S Kurokawa; A C B Rizzo; C C da Silva; A Dos Santos Teixeira; J E Corrente Journal: Osteoporos Int Date: 2016-11-30 Impact factor: 4.507
Authors: Zoe M González-García; Iftikhar J Kullo; Dawn K Coletta; Lawrence J Mandarino; Gabriel Q Shaibi Journal: Am J Hum Biol Date: 2015-06-19 Impact factor: 1.937
Authors: Samuel D Vasikaran; Sa Paul Chubb; Peter R Ebeling; Nicole Jenkins; Graham Rd Jones; Mark A Kotowicz; Howard A Morris; Hans-Gerhard Schneider; Markus J Seibel; Greg Ward Journal: Clin Biochem Rev Date: 2014-11
Authors: Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Aiello; Julia F Charles; Laura L Hernandez Journal: Am J Physiol Endocrinol Metab Date: 2018-10-23 Impact factor: 4.310